3,013
Views
30
CrossRef citations to date
0
Altmetric
Commentary

Recent advancements in combination subunit vaccine development

&
Pages 180-185 | Received 04 Aug 2016, Accepted 24 Aug 2016, Published online: 26 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ming Xia, Frank Vago, Ling Han, Pengwei Huang, Linh Nguyen, Geert-Jan Boons, John S Klassen, Wen Jiang & Ming Tan. (2023) The αTSR Domain of Plasmodium Circumsporozoite Protein Bound Heparan Sulfates and Elicited High Titers of Sporozoite Binding Antibody After Displayed by Nanoparticles. International Journal of Nanomedicine 18, pages 3087-3107.
Read now
B. N. Umar, J Adamu, M. T Ahmad, K. H. Ahmad, A. Sada & O. Orakpoghenor. (2021) Fowlpox virus: an overview of its classification, morphology and genome, replication mechanisms, uses as vaccine vector and disease dynamics. World's Poultry Science Journal 77:4, pages 929-947.
Read now
Xi Jiang, Yang Liu & Ming Tan. (2017) Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy. Emerging Microbes & Infections 6:1, pages 1-8.
Read now

Articles from other publishers (27)

Ruiming Yu, Liping Zhang, Peng Zhou, Zhongwang Zhang, Xiaoqing Liu, Yonglu Wang, Huichen Guo, Li Pan & Xinsheng Liu. (2024) Evaluation of the immunoprotective effects of porcine deltacoronavirus subunit vaccines. Virology 590, pages 109955.
Crossref
Parisa Hashemi, Shirin Mahmoodi & Abdolmajid Ghasemian. (2023) An updated review on oral protein-based antigen vaccines efficiency and delivery approaches: a special attention to infectious diseases. Archives of Microbiology 205:8.
Crossref
Ming Xia, Krisangel López, Frank S. Vago, Pengwei Huang, Dawn I. Auguste, Wen Jiang, Albert J. Auguste & Ming Tan. (2023) A bioengineered pseudovirus nanoparticle displaying SARS‐CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS‐CoV 2 challenge. Biotechnology Journal.
Crossref
Luis Giovani Oliveira Guardalini, Jaci Leme, Paulo Eduardo da Silva Cavalcante, Renata Gois de Mello, Thaissa Consoni Bernardino, Simone Gonçalves Silva Jared, Marta Maria Antoniazzi, Renato Mancini Astray, Aldo Tonso, Eutimio Gustavo Fernández Núñez & Soraia Attie Calil Jorge. (2023) Sf9 Cell Metabolism Throughout the Recombinant Baculovirus and Rabies Virus-Like Particles Production in Two Culture Systems. Molecular Biotechnology.
Crossref
Krithiga Natesan, Shrikrishna Isloor, Balamurugan Vinayagamurthy, Sharada Ramakrishnaiah, Rathnamma Doddamane & Anthony R. Fooks. (2023) Developments in Rabies Vaccines: The Path Traversed from Pasteur to the Modern Era of Immunization. Vaccines 11:4, pages 756.
Crossref
Annamalai RamaAnuja PaiDivya Rosa BarretoSiva Kumar KannanAnup Naha. (2022) Virus-Like particles as a Novel Targeted Drug Delivery Platform for Biomedical Applications. Research Journal of Pharmacy and Technology, pages 2801-2808.
Crossref
Ming Xia, Md Rejaul Hoq, Pengwei Huang, Wen Jiang, Xi Jiang & Ming Tan. (2022) Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity. Nano Research 15:5, pages 4181-4190.
Crossref
Ishan Ghosh & Mohit D. Gandhi. (2022) Emerging Frontiers in Vaccine Development: A Review of Changing Paradigm. Journal of Biosciences and Medicines 10:07, pages 123-145.
Crossref
Tianyu Lu, Nouredine Behloul, Yi Zhou, Sarra Baha, Zhenzhen Liu, Wenjuan Wei, Rui-Hua Shi & Jihong Meng. (2022) Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles. Intervirology 65:1, pages 37-48.
Crossref
Lucía Lara Rupil, Marianela del Carmen Serradell & Hugo Daniel Luján. 2022. Vaccine Design. Vaccine Design 503 537 .
Eknath D. Ahire & Sanjay J Kshirsagar. (2021) Immune responses induced by different vaccine platforms against coronavirus disease-19. Exploration of Immunology, pages 243-257.
Crossref
Raquel Cid & Jorge Bolívar. (2021) Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies. Biomolecules 11:8, pages 1072.
Crossref
Wai Chin Chong, Dinesh K. Chellappan, Shakti D. Shukla, Gregory M. Peterson, Rahul P. Patel, Niraj Kumar Jha, Rajaraman D. Eri, Kamal Dua, Murtaza M. Tambuwala & Madhur D. Shastri. (2021) An Appraisal of the Current Scenario in Vaccine Research for COVID-19. Viruses 13:7, pages 1397.
Crossref
Nidhi Chauhan, Shringika Soni, Abhinandan Gupta, Mohammad Aslam & Utkarsh Jain. (2020) Interpretative immune targets and contemporary position for vaccine development against SARS‐CoV‐2: A systematic review. Journal of Medical Virology 93:4, pages 1967-1982.
Crossref
Shipra Sharma, Vibha Kumari, Bajarang Vasant Kumbhar, Amrita Mukherjee, Ruchika Pandey & Kiran Kondabagil. (2021) Immunoinformatics approach for a novel multi-epitope subunit vaccine design against various subtypes of Influenza A virus. Immunobiology 226:2, pages 152053.
Crossref
Saima Ashraf, Nabila Bashir, Nadia Rashid, Adeel Hussain Chughtai, Khalid Mahmood Zia, Saadat Majeed, Muhammad Naeem Ashiq, Ghulam Murtaza & Muhammad Najam-ul-Haq. 2021. Biochemistry of Drug Resistance. Biochemistry of Drug Resistance 1 31 .
Jin Xiang Wong, Kampachiro Ogura, Shuxiong Chen & Bernd H. A. Rehm. (2020) Bioengineered Polyhydroxyalkanoates as Immobilized Enzyme Scaffolds for Industrial Applications. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Joan Kha-Tu Ho, Beena Jeevan-Raj & Hans-Jürgen Netter. (2020) Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms. Viruses 12:2, pages 126.
Crossref
Tan & Jiang. (2019) Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development. Pharmaceutics 11:9, pages 472.
Crossref
Mehdi R.M. Bidokhti, Karin Ullman, Anne Sofie Hammer, Trine Hammer Jensen, Mariann Chriél, Siddappa N. Byrareddy & Claudia Baule. (2019) Immunogenicity and Efficacy Evaluation of Subunit Astrovirus Vaccines. Vaccines 7:3, pages 79.
Crossref
A. V. Dobrovolskiy. (2019) Approaches to Clinical Development of Combination Medicines in the Russian Federation and the Eurasian Economic Union in view of the Requirements of the Current Legislation. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 9:1, pages 14-27.
Crossref
Ming Xia, Pengwei Huang, Chen Sun, Ling Han, Frank S. Vago, Kunpeng Li, Weiming Zhong, Wen Jiang, John S. Klassen, Xi Jiang & Ming Tan. (2018) Bioengineered Norovirus S 60 Nanoparticles as a Multifunctional Vaccine Platform . ACS Nano 12:11, pages 10665-10682.
Crossref
Nina Sanina, Natalia Chopenko, Andrey Mazeika, Ludmila Davydova, Galina Leonova, Anna Stenkova, Vladimir Uversky & Eduard Kostetsky. (2018) Immunogenicity and Protective Activity of a Chimeric Protein Based on the Domain III of the Tick-Borne Encephalitis Virus E Protein and the OmpF Porin of Yersinia pseudotuberculosis Incorporated into the TI-Complex. International Journal of Molecular Sciences 19:10, pages 2988.
Crossref
Qianniu Li, Zhichao Xu, Tingting Wu, Ouyang Peng, Licheng Huang, Yun Zhang, Chunyi Xue, Zhifen Wen, Qingfeng Zhou & Yongchang Cao. (2018) A flagellin-adjuvanted PED subunit vaccine improved protective efficiency against PEDV variant challenge in pigs. Vaccine 36:29, pages 4228-4235.
Crossref
J. Rajčáni & S. Szathmary. (2018) Peptide Vaccines: New Trends for Avoiding the Autoimmune Response. The Open Infectious Diseases Journal 10:1, pages 47-62.
Crossref
Qianniu Li, Ouyang Peng, Tingting Wu, Zhichao Xu, Licheng Huang, Yun Zhang, Chunyi Xue, Zhifen Wen, Qingfeng Zhou & Yongchang Cao. (2018) PED subunit vaccine based on COE domain replacement of flagellin domain D3 improved specific humoral and mucosal immunity in mice. Vaccine 36:11, pages 1381-1388.
Crossref
Satarudra Prakash Singh, Deeksha Srivastava & Bhartendu Nath Mishra. (2017) Genome-wide identification of novel vaccine candidates for Plasmodium falciparum malaria using integrative bioinformatics approaches. 3 Biotech 7:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.